Grants per year
Search results
-
Active
-
Protocol R2222-RSV-1332, A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically Attended RSV Infection in Preterm Infants
Yogev, R. (PD/PI)
Regeneron Pharmaceuticals, Inc.
10/14/15 → 8/31/50
Project: Research project
-
1425601: Clinical Evaluation of the Alere? i RSV, Protocol Number: 1425601, PPR and Laboratory Services Agreement
Yogev, R. (PD/PI)
1/1/15 → 8/31/50
Project: Research project
-
1425601: Clinical Evaluation of the Alere? i RSV, Protocol Number: 1425601, PPR and Laboratory Services Agreement
Yogev, R. (PD/PI)
1/1/15 → 8/31/50
Project: Research project